| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283119A Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 02/07/2001 | CN1282607A 'Zhixueling'-for treating external hemorrhage of cut and injuries |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184233 Crystals having storage stability, oral absorption, solubility; hypotensive agents, platelet agglutination control agents |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184211 Inhibition of DNA methyltransferase |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183775 Buccal delivery system |
| 02/06/2001 | US6183756 Methods for prevention and/or treatment of thrombocytopenia |
| 02/06/2001 | US6183651 Blood processing systems and methods which optically monitor plasma opacity |
| 02/06/2001 | CA2315309A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of affinity chromatography |
| 02/06/2001 | CA2315306A1 Process for the preparation in pure form of the protease activating blood clotting factor vii, its proenzyme or a mixture of both proteins by means of ion-exchange chromatography |
| 02/06/2001 | CA2106612C Displacement chromatography process |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/01/2001 | WO2001007918A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007612A2 Receptors and associated proteins |
| 02/01/2001 | WO2001007595A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007436A2 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | WO2001007423A1 Drug compositions exhibiting thrombopoietin agonism |
| 02/01/2001 | WO2001007098A2 A device and method for performing a biological modification of a fluid |
| 02/01/2001 | WO2001007078A1 Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases |
| 02/01/2001 | WO2001007074A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | WO2001007072A1 Modulation of platelet activation |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2000059493A3 Improved dialysis solutions and methods |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000053733A3 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380206A1 Pharmaceutical compositions exhibiting thrombopoietin receptor agonism |
| 02/01/2001 | CA2379937A1 A device and method for performing a biological modification of a fluid |
| 02/01/2001 | CA2379818A1 Catalytic anti-factor viii allo-antibodies |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378776A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of medicament for the treatment of glycolipid storage diseases |
| 02/01/2001 | CA2378473A1 Modulation of platelet activation |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1071795A1 Canine erythropoietin gene and recombinant protein |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071768A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum |
| 01/31/2001 | EP1071751A1 TRANSGENIC MAMMALS EXPRESSING MUTANT GP IIIa |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071669A1 Bicyclic compounds having an anti-thrombitic effect |
| 01/31/2001 | EP1071433A2 Pharmaceutical composition |
| 01/31/2001 | EP1071427A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 01/31/2001 | CN1282337A Cyclopeptide derivatives with integrin inhibitor properties |
| 01/31/2001 | CN1282329A I (ortho)-anthranilamide derivatives as anti-coagulants |
| 01/31/2001 | CN1282320A Thermodynamically stable from of (R)-3-[[(4-fluorophenyl) sulphonyl] amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid (ramatroban) |
| 01/31/2001 | CN1281709A Chinese patent medicine for curing thrombotic disease |
| 01/31/2001 | CN1281702A Powder and paster for promoting blood circulation and their-matched products |
| 01/31/2001 | CN1061341C 1-amino-ethylindole-derivatives |
| 01/31/2001 | CN1061251C Chinese patnet drug for curing hemalopia |
| 01/31/2001 | CN1061233C Health-care oral liquor and its producing process |
| 01/30/2001 | US6180793 Process for the preparation of a pharmacologically active substance |
| 01/30/2001 | US6180759 Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides |
| 01/30/2001 | US6180664 Pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 01/30/2001 | US6180627 Antithrombotic agents |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/30/2001 | US6180371 Modified factor VIII |
| 01/30/2001 | US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities |
| 01/30/2001 | CA2272317C Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound |
| 01/30/2001 | CA2139931C Purification of factor ix |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/30/2001 | CA2052013C Tripeptide antithrombotic agents |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005966A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 01/25/2001 | WO2001005944A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | WO2001005937A2 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005810A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 01/25/2001 | WO2001005802A1 Antisense modulation of fadd expression |
| 01/25/2001 | WO2001005784A1 NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005764A2 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester |
| 01/25/2001 | WO2001005753A1 Diacylhydrazine derivatives |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005749A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005414A1 Algae protein polysaccharide extraction and use thereof |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/25/2001 | WO2000066550A8 New compounds |
| 01/25/2001 | WO2000066111B1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2380727A1 Nitrogen containing heterobicycles as factor xa inhibitors |